Veterinary infectious disease is a disease that can be transmitted from one animal to another or from another human being by pathogenic microorganisms.If not treated, will quickly infect animals, animals, will directly result in dairy, food and beverage industry, textile industry future risk, to food service industry, food industry, and families have a negative impact, not only pose a threat to animal veterinary infectious diseases, and pose a threat to humans, their treatment is widely used in veterinary hospital, veterinary clinic, the vet pharmacy, scientific research institutes.
This report contains market size and forecasts of Veterinary Infectious Diseases Therapeutics in global, including the following market information:
Global Veterinary Infectious Diseases Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Veterinary Infectious Diseases Therapeutics Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Veterinary Infectious Diseases Therapeutics companies in 2021 (%)
The global Veterinary Infectious Diseases Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Veterinary Infectious Diseases Therapeutics include Elanco Animal Health, Novartis Animal Health, Merck, Pfizer Animal Health, Sanofi, Boehringer Ingelheim Vetmedica, Dechra Animal Health, Ceva Sante Animale and Elanco Animal Health and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Infectious Diseases Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Infectious Diseases Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Veterinary Infectious Diseases Therapeutics Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Antiviral
Antifungal
Amebicides
Anthelmintics
Global Veterinary Infectious Diseases Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Veterinary Infectious Diseases Therapeutics Market Segment Percentages, by Application, 2021 (%)
Swine
Chicken
Dog
Cat
Cow
Horse
Other
Global Veterinary Infectious Diseases Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Veterinary Infectious Diseases Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Infectious Diseases Therapeutics revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Veterinary Infectious Diseases Therapeutics revenues share in global market, 2021 (%)
Key companies Veterinary Infectious Diseases Therapeutics sales in global market, 2017-2022 (Estimated), (KG)
Key companies Veterinary Infectious Diseases Therapeutics sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Elanco Animal Health
Novartis Animal Health
Merck
Pfizer Animal Health
Sanofi
Boehringer Ingelheim Vetmedica
Dechra Animal Health
Ceva Sante Animale
Elanco Animal Health
Virbac